Intravenous immunoglobulin therapy — most commonly known as IVIG therapy — is one of the more remarkable treatments in modern medicine. It uses a concentrated preparation of antibodies donated by thousands of healthy individuals to help patients whose own immune systems are either deficient or misdirected. For patients with certain neurological conditions, immune deficiencies, or autoimmune diseases, IVIG therapy can bring meaningful relief and, in some cases, dramatic improvement.
What is IVIG therapy?
IVIG stands for intravenous immunoglobulin. Immunoglobulins are antibodies — proteins your immune system produces to recognize and neutralize threats like bacteria, viruses, and other foreign substances. IVIG therapy is made from pooled plasma donated by thousands of healthy donors. The plasma is carefully processed to concentrate the immunoglobulins and screened rigorously for safety. The resulting product contains a broad spectrum of antibodies that can be infused directly into a patient’s bloodstream.
Depending on the condition being treated, IVIG therapy works through two broad mechanisms:
- Replacement — In patients with primary or secondary immune deficiencies, IVIG supplements the antibodies their body cannot produce in sufficient quantities, reducing the frequency and severity of infections.
- Immunomodulation — In autoimmune and inflammatory conditions, IVIG helps regulate or "calm" an overactive immune system that is attacking the body’s own tissues.
Conditions treated with IVIG therapy
IVIG therapy has FDA approval for several conditions and is used off-label for many others under physician supervision.
Immune deficiency conditions: Primary immunodeficiency diseases (such as common variable immunodeficiency); secondary immunodeficiencies related to certain cancers or treatments.
Neurological conditions: Guillain-Barré syndrome — an acute neurological emergency where IVIG can halt and reverse nerve damage; chronic inflammatory demyelinating polyneuropathy (CIDP); multifocal motor neuropathy; myasthenia gravis; dermatomyositis and polymyositis.
Other autoimmune and inflammatory conditions: Kawasaki disease (particularly in children); immune thrombocytopenia (ITP); certain inflammatory conditions as directed by a specialist.
What does an IVIG infusion involve?
Before the infusion: Your nurse will review your health history, allergies, and current medications. Vital signs are recorded. Some patients receive pre-medications — typically antihistamines and/or acetaminophen — to reduce the risk of headache or infusion-related reactions. Staying well-hydrated before your appointment is particularly important for IVIG therapy, as good hydration reduces the risk of headache afterward.
During the infusion: IVIG is infused slowly, particularly at the start, to reduce the risk of reactions. Your nurse will gradually increase the infusion rate as it is tolerated. IVIG therapy sessions are among the longer infusions — most last between 3 and 6 hours, though this varies based on your dose and the specific product being used. Bring comfort items: headphones, a book, snacks, a phone charger.
After the infusion: You’ll be monitored for 30 to 60 minutes before leaving. Because of the length of IVIG infusion sessions, many patients feel fatigued afterward. Plan for a lighter schedule on your infusion day.
Managing IVIG side effects
- Headache — the most common side effect, often related to the infusion rate or hydration status. Drinking plenty of water before and after your infusion significantly reduces this risk.
- Fatigue — feeling tired the day of and the day after infusion is normal and typically resolves quickly.
- Flu-like symptoms — some patients experience chills, mild fever, or muscle aches, particularly after their first few infusions.
- Flushing, nausea, or blood pressure changes — these infusion reactions are monitored closely by our nursing staff, and the infusion rate can be slowed if needed.
Serious reactions are uncommon but can occur, which is why IVIG therapy must be administered in a clinical setting like Arbor — never at home without appropriate medical oversight.
How often is IVIG therapy given?
For immune deficiency replacement, IVIG is typically given every three to four weeks on an ongoing basis. For neurological conditions like CIDP, dosing may begin more frequently and then be spaced out as your condition stabilizes. For acute conditions like Guillain-Barré, IVIG may be given in a concentrated short course.
Partnering with Arbor for your IVIG treatment
IVIG therapy requires skill, patience, and attentive nursing care. Our team has extensive experience administering IVIG across a wide range of conditions. We coordinate directly with your prescribing physician, monitor you carefully throughout each session, and are here to answer your questions every step of the way.